Ares Capital CorporationAres Capital is a major BDC; rising non-accruals signal credit deterioration affecting its portfolio.
Non-accrual debt across US-registered business development companies jumped to 1.9% of total debt at cost in Q1 2026, up 52 basis points from the prior quarter, signaling growing borrower distress in private credit. Adjusted non-accrual exposure, counting all debt owed by borrowers with at least one non-accrual tranche, rose to 3.3% of total debt at cost, up 116 basis points from Q4 2025. Among the ten largest publicly traded BDCs, reported non-accrual debt reached 3.95% of total debt at cost in Q2, up 20 basis points, while adjusted exposure rose 54 basis points to 5.95%. The number of borrowers with at least one non-accrual instrument climbed to 356 in Q1 2026, representing 4.69% of all borrowers, up from 4.26% a year earlier. Two borrowers, Medallia and Inovalon, accounted for $4.4 billion of the Q1 2026 non-accrual total.
Ares Capital CorporationAres Capital is a major BDC; rising non-accruals signal credit deterioration affecting its portfolio.
FS KKR Capital CorpFS KKR Capital Corp faces increased non-accruals, indicating borrower distress in its loan book.
Golub Capital BDC IncGolub Capital BDC's non-accrual rates rise, reflecting credit quality issues.
Goldman Sachs BDC IncGoldman Sachs BDC sees higher non-accruals, impacting earnings and asset quality.
Main Street Capital CorporationMain Street Capital's non-accrual exposure increases, signaling potential credit losses.
MidCap Financial Investment CorporationBDC sector non-accruals rising signals credit deterioration, impacting MFIC's loan portfolio.
Blue Owl Capital CorporationBDC sector non-accruals rising signals credit deterioration, impacting Blue Owl's loan portfolio.
Sixth Street Specialty Lending IncBDC sector non-accruals rising signals credit deterioration, impacting Sixth Street's loan portfolio.
Inovalon is named as one of two borrowers accounting for $4.4B of non-accruals, indicating financial distress.
Medallia is named as one of two borrowers accounting for $4.4B of non-accruals, indicating financial distress.